Microbe/phage investigation for generalized health therapy
Active Other Transaction Agreement Awarded Last action
- Contract number
- 140D042590030
- Awardee
-
University Of Illinois UEI Y8CWNJRCNN91
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $28,073,294
Award facts
- Contract value 86% obligated
-
- $28,073,294.00 Current, with exercised options
- $32,751,928.00 Potential, with all options
- Completion date 23% complete
- Current and potential, with all options
- Funding agency
- National Institutes of Health Department of Health and Human Services
- NAICS code
- Not on record
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Urbana, IL 61801, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $28,073,294 |
About this award
The National Institutes of Health awarded an Other Transaction Agreement to the University of Illinois for Microbe/Phage Investigation for Generalized Health Therapy with a ceiling value of $32,751,928 on September 22, 2025. This OTA sits outside the FAR and operates under 10 U.S.C. § 4022 or related statutory authority for prototype, research, or production transactions. Performance is scheduled through September 21, 2030, with place of performance in Urbana, Illinois.
The agreement engages a multi-institution research team. Subcontractors include the Regents of the University of Minnesota (awarded March 27, 2026), Oregon State University (February 11, 2026), Ginkgo Bioworks, Inc. (November 7, 2025), and Baylor University (November 6, 2025). The collaboration spans biomedical research capabilities across genomic surveillance, pathogen detection, synthetic biology, microbiome analysis, and specialized laboratory services. Ginkgo Bioworks brings metagenomic next-generation sequencing and pathogen identification expertise; Minnesota and Oregon State contribute research infrastructure and laboratory analysis; Baylor provides research coordination and analysis support.
The OTA funds exploratory development and applied research into bacteriophage and microbial therapeutic applications, building on federal interest in novel health intervention modalities. The University of Illinois, as prime, integrates contributions from partner institutions into a coordinated research execution model typical of large, multi-site translational science efforts within NIH's portfolio.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Regents Of The University Of Minnesota | $643,571 | |
| Oregon State University | $151,273 | |
| Ginkgo Bioworks, Inc. | $902,193 | |
| Baylor University | $1,217,168 |
Quick answers
Who was awarded contract 140D042590030?
140D042590030 was awarded to University Of Illinois by Interior Business Center (Office of Policy Management and Budget) on September 22, 2025.
How much is contract 140D042590030 worth?
The government has obligated $28,073,294 on 140D042590030. Its potential value, with all options, is $32,751,928.
Which agency awarded contract 140D042590030?
Interior Business Center (Office of Policy Management and Budget) awarded 140D042590030, with funding from National Institutes of Health (Department of Health and Human Services).
Was contract 140D042590030 competed?
The extent of competition for 140D042590030 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award